Clostridium Difficile Antibodies

Posted: 03/31/2009

The bacterium Clostridium difficile causes acute diarrhea. Once thought to be the result of aggressive antibiotic therapy in healthcare settings only, it is now more frequently occurring in healthy individuals and is considered by many as an emerging pathogen.

The symptoms are caused by two toxins that the organism produces, Toxin A and Toxin B. ViroStat, Inc. has recently released a new set of Monoclonal Antibodies to each of these toxins. These valuable tools will aid researchers who are studying the pathogenesis of this organism. These high affinity antibodies can also be used for the rapid detection of toxins directly in stool. Download the data sheet for these NEW Antibodies, click here to obtain pricing, or contact us for more information.

ViroStat, Inc. is a primary manufacturer of infectious disease antigens and antibodies, supplying researchers and manufacturers since 1985. Specialties include high affinity antibodies to Flu A, Flu B, RSV & Strep A for use in rapid lateral flow devices as well as antibodies to food-borne pathogens and toxins. Also, many specificities to HCV, HBV, CMV & EBV for use in anti-viral HTS assays.